| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥192.7B | ¥162.5B | +18.6% |
| Operating Income | ¥28.6B | ¥24.1B | +18.6% |
| Ordinary Income | ¥30.3B | ¥23.4B | +29.5% |
| Net Income | ¥21.3B | ¥17.1B | +24.5% |
| ROE | 7.0% | 6.1% | - |
FY2026 Q2 results: Revenue 192.7B yen (YoY +18.6%), Operating Income 28.6B yen (+18.6%), Ordinary Income 30.3B yen (+29.5%), and Net Income 21.3B yen (+24.5%). The company delivered double-digit growth across all profit levels, with revenue increasing by 30.2B yen year-over-year. Gross profit margin remained stable at 21.9%, while selling, general and administrative expenses were well-controlled at 13.6B yen, maintaining an operating margin of approximately 14.8%. The operating cash flow to net income ratio of 1.66x indicates strong cash generation capability. Total assets increased to 436.2B yen with equity reaching 305.2B yen, resulting in an equity ratio of 70.0%. The balance sheet remains conservative with interest-bearing debt reduced to 11.3B yen.
Revenue growth of 18.6% was primarily driven by expanded sales volume and positive foreign exchange effects. The gross profit reached 42.2B yen with a consistent gross margin of 21.9%, demonstrating pricing power and stable cost management despite increased sales volume. Operating expenses increased modestly to 13.6B yen, growing at a rate below revenue growth, which contributed to operating leverage improvement. The operating income of 28.6B yen represents an operating margin of 14.8%, maintaining profitability levels from the prior year. The significant gap between ordinary income (30.3B yen, +29.5%) and operating income (28.6B yen, +18.6%) reflects positive non-operating contributions of approximately 1.7B yen, primarily from equity method gains and financial income. The differential between ordinary income (30.3B yen) and net income (21.3B yen) of approximately 9.0B yen represents an effective tax rate of 29.5%. Non-recurring factors were minimal, with no material impairment or restructuring charges disclosed. This represents a revenue up, profit up pattern, with ordinary income growth outpacing operating income growth due to favorable non-operating factors.
The Parts segment represents the core business with revenue of 147.1B yen and operating income of 30.1B yen, accounting for approximately 76.3% of total segment sales. This segment demonstrated the highest absolute profit contribution. The Machinery and Appliances segment generated revenue of 36.9B yen with operating income of 4.1B yen, representing an operating margin of approximately 11.2%. The Rental segment contributed revenue of 1.8B yen with operating income of 0.5B yen, showing a margin of approximately 25.8%, the highest among segments. The Die segment recorded revenue of 10.7B yen with operating income of 1.5B yen, representing a margin of approximately 14.3%. Segment profit totaled 36.2B yen before corporate allocation adjustments of negative 7.5B yen, which includes intersegment eliminations of negative 0.3B yen, unallocated corporate expenses of negative 6.6B yen (primarily general administration and R&D costs), and inventory adjustments of negative 0.5B yen. The Parts segment's dominance and strong profitability anchors overall performance, while the Rental segment demonstrates superior margin characteristics despite its smaller scale.
[Profitability] ROE 6.2% represents the annualized return based on H1 net income, calculated through DuPont analysis as net profit margin 9.8% multiplied by total asset turnover 0.442 and financial leverage 1.43x. Operating margin of 14.8% reflects strong operational efficiency, with gross margin at 21.9%. The EBIT margin of 14.8% combined with an interest burden factor of 1.059 indicates minimal interest expenses. [Cash Quality] Cash and deposits of 74.6B yen provide coverage of 8.79x against short-term borrowings of 8.5B yen, indicating substantial liquidity. Operating cash flow of 31.3B yen represents 1.66x net income, confirming high-quality earnings backed by cash generation. [Investment Efficiency] Total asset turnover of 0.442 reflects an annualized revenue-to-asset ratio. Days sales outstanding of 153 days and days inventory outstanding of 118 days indicate areas for working capital improvement. [Financial Health] Equity ratio of 70.0% (305.2B yen equity against 436.2B yen total assets) demonstrates conservative capitalization. Current ratio of 202.4% and quick ratio of 198.7% indicate strong short-term liquidity. Debt-to-equity ratio of 0.04 (interest-bearing debt 11.3B yen against equity 305.2B yen) reflects minimal leverage. Interest coverage ratio of 188x demonstrates negligible debt burden.
Operating cash flow of 31.3B yen represents 1.66x of net income of 18.9B yen, confirming cash-backed earnings quality. The operating CF to EBITDA ratio of 0.77x indicates solid conversion of operating profit to cash. Investing cash flow consumed 13.0B yen, primarily driven by capital expenditures of 8.0B yen and a significant increase in investment securities of 19.5B yen. The CapEx to depreciation ratio of 0.65x suggests restrained capital investment relative to asset consumption. Free cash flow of 18.3B yen was generated after investing activities, providing 1.49x coverage of the full-year dividend projection. Financing activities reflected debt reduction with short-term borrowings decreasing 4.3B yen and long-term debt declining 3.0B yen. The negative accrual ratio of negative 2.8% indicates earnings quality remains healthy with minimal accrual-based income. Cash and deposits increased from prior levels, supporting strong liquidity position. Working capital movements show accounts receivable increasing to 81.0B yen with DSO extending to 153 days, and work-in-process inventory growth contributing to the 118-day DIO, both indicating efficiency deterioration requiring management attention.
Ordinary income of 30.3B yen versus operating income of 28.6B yen shows a positive non-operating net contribution of approximately 1.7B yen. This comprises equity method investment gains and financial income as primary components, with the interest burden factor of 1.059 indicating net non-operating income adds approximately 5.9% to operating profit. Non-operating income represents less than 1% of revenue at approximately 1.7B yen out of 192.7B yen in sales, consisting primarily of interest and dividend income with minimal foreign exchange impact disclosed. The tax burden factor of 0.624 reflects an effective tax rate of approximately 29.5%, in line with standard corporate taxation. Operating cash flow of 31.3B yen significantly exceeds net income of 18.9B yen by a factor of 1.66x, indicating healthy earnings quality with strong cash realization. The negative accrual ratio of negative 2.8% further confirms that earnings are not inflated by accrual accounting. However, the extension of accounts receivable days (DSO 153 days) and inventory days (DIO 118 days, including elevated work-in-process) suggests some deterioration in working capital efficiency that warrants monitoring for potential impact on future cash conversion quality.
The company maintains its full-year guidance with revenue of 374.6B yen (YoY +12.4%), operating income of 48.0B yen (+11.7%), and ordinary income of 49.7B yen (+18.1%). Based on H1 results, the progress rates are: Revenue 51.4% (192.7B yen against 374.6B yen target), Operating Income 59.6% (28.6B yen against 48.0B yen target), and Ordinary Income 61.0% (30.3B yen against 49.7B yen target). All metrics exceed the standard 50% H1 benchmark, indicating ahead-of-schedule performance. Operating income and ordinary income progress rates running approximately 10 percentage points ahead of revenue suggest stronger-than-expected profitability in H1, potentially due to favorable product mix, operating leverage, or non-operating gains. The full-year dividend per share is projected at 50 yen, with an interim dividend of 40 yen already paid. The ahead-of-pace profit achievement suggests upside potential to guidance, though management has not revised targets upward at this point. Key assumptions likely include sustained demand conditions and stable foreign exchange rates for H2 to achieve the conservative full-year projections.
The company forecasts a full-year dividend of 50 yen per share, consisting of an interim dividend of 40 yen (paid) and a year-end dividend of 10 yen (planned). Based on the full-year net income forecast of 31.2B yen and basic shares outstanding of approximately 14.4 million shares (derived from forecasted EPS of 217.07 yen), the projected payout ratio is approximately 23.0% against full-year earnings. However, based on H1 net income of 18.9B yen annualized, the effective payout ratio would be approximately 64.8%, indicating H1 earnings are tracking ahead of full-year guidance. Free cash flow of 18.3B yen in H1 provides coverage of 1.49x against the annualized dividend outlay, demonstrating sustainability. No share buyback program has been disclosed in the current period. The dividend policy appears conservative relative to the company's strong cash generation and low leverage, with potential room for increased shareholder returns given the robust financial position and FCF coverage.
Working capital efficiency deterioration poses operational risk, with days sales outstanding extending to 153 days and days inventory outstanding at 118 days, both triggering quality alerts. The elevated work-in-process inventory suggests potential production bottlenecks or demand forecasting mismatches that could impact future revenue conversion and cash flow. Asset allocation shift toward investment securities, which increased 75.6% or 19.5B yen to reach 45.2B yen, introduces market valuation risk and potential unrealized losses during market downturns, while also contributing to lower total asset turnover of 0.442x. The capital expenditure to depreciation ratio of 0.65x indicates potential underinvestment in productive capacity, which may constrain future growth capability or competitiveness if sustained. While short-term financial health is strong, prolonged CapEx restraint could erode manufacturing capabilities in a capital-intensive industry.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating Margin 14.8% substantially exceeds the industry median of 6.1% (IQR: negative 2.1% to 19.4%, n=4), positioning the company in the upper quartile. Net Profit Margin of 9.8% similarly outperforms the industry median of 5.0% (IQR: negative 2.2% to 14.6%), demonstrating superior earnings conversion. ROE of 6.2% (annualized from H1) compares favorably to the industry median of 4.2% (IQR: negative 0.9% to 9.0%).
Financial Health: Equity Ratio of 70.0% significantly exceeds the industry median of 61.1% (IQR: 44.1% to 77.0%), indicating a more conservative capital structure. Current Ratio of 202.4% is below the industry median of 274% (IQR: 227% to 543%), though absolute liquidity remains strong given substantial cash holdings relative to short-term obligations.
Efficiency: Revenue Growth of 18.6% outpaces the industry median of 5.2% (IQR: negative 3.4% to 19.2%), placing the company among growth leaders. However, Asset Turnover of 0.442 exceeds the industry median of 0.36 (IQR: 0.31 to 0.43), indicating relatively better asset utilization despite concerns about working capital. Days Receivables Outstanding of 153 days significantly exceeds the industry median of 76.5 days (IQR: 59.0 to 88.3 days), and Days Inventory Outstanding of 118 days is below the median of 170.5 days (IQR: 101.2 to 243.2 days), suggesting mixed working capital performance with particular weakness in receivables management.
Cash Flow: Cash Conversion Ratio of 1.66x (operating CF to net income) substantially exceeds the industry median of 1.02x (IQR: negative 1.10 to 1.16), demonstrating superior cash generation quality.
※ Industry: Manufacturing sector (n=4 companies), Comparison: FY2025-Q2 period, Source: Proprietary analysis
The company demonstrates exceptional profitability and cash generation relative to industry peers, with operating margins more than double the sector median and revenue growth significantly outpacing competitors. The conservative balance sheet with 70% equity ratio and minimal leverage provides substantial financial flexibility for future investments or enhanced shareholder returns. However, the deterioration in working capital efficiency, particularly the 153-day receivables collection period that is double the industry norm, represents a key area requiring management attention and could constrain future cash flow quality if not addressed. The substantial increase in investment securities by 19.5B yen shifts the asset mix toward financial assets rather than productive capacity, which combined with below-replacement CapEx levels may limit long-term competitive positioning in a manufacturing industry requiring ongoing capital investment for technology and capacity maintenance.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.